Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001564590-21-034575

Agreement ended · Other events

  • Item 1.02 Termination of a material definitive agreement
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading fdmt-8k_20210618.htm…